Tiespectus

DRUG2 trials

Sponsors

EyeBiotech Ltd.

Conditions

Age-Related Macular DegenerationChoroidal NeovascularizationMacular DegenerationWet Macular Degeneration

Phase 2

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

RecruitingNCT07440225

EyeBiotech Ltd.Age-Related Macular Degeneration, Choroidal Neovascularization, Macular Degeneration +1

Start: 2026-03-27End: 2028-06-30Target: 960Updated: 2026-09-02

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

RecruitingNCT07496567

EyeBiotech Ltd.Age-Related Macular Degeneration, Choroidal Neovascularization, Macular Degeneration +1

Start: 2026-04-15End: 2028-07-31Target: 960Updated: 2026-08-06